Anti-Pdcd4 pS457 Antibody
Produktgrößen
1 mg
£3866,00
OARA02821-1MG
Über dieses Produkt
- SKU:
- OARA02821
- Zusätzliche Namen:
- H731;neoplastic transformation inhibitor protein;nuclear antigen H731;Nuclear antigen H731-like;programmed cell death 4 (neoplastic transformation inhibitor);programmed cell death protein 4;protein 197/15a.
- translate.label.attr.clone:
- 2E10.C12
- Klonalität:
- Monoclonal
- Konjugat:
- Unconjugated
- Konzentration:
- 1 mg/ml
- Weitere Details:
- Inhibits translation initiation and cap-dependent translation. May excert its function by hindering the interaction between EIF4A1 and EIF4G. Inhibits the helicase activity of EIF4A. Modulates the activation of JUN kinase. Down-regulates the expression of MAP4K1; thus inhibiting events important in driving invasion; namely; MAPK85 activation and consequent JUN-dependent transcription. May play a role in apoptosis. Tumor suppressor. Inhibits tumor promoter-induced neoplastic transformation. Binds RNA (By similarity).
- Gendetails:
- programmed cell death 4
- Host:
- Mouse
- Immunogen:
- Anti-Pdcd4 phospho S457 Antibody was produced by repeated immunizations with a synthetic peptide corresponding to residues surrounding Ser457 of the human Pdcd4 protein.
- Proteindetails:
- Programmed cell death protein 4
- Versandbedingungen:
- Dry Ice
- Lagerbedingungen:
- Store vial at -20 C prior to opening. Â This product is stable for several weeks at 4 C as an undiluted liquid. Â Dilute only prior to immediate use. Â For extended storage aliquot contents and freeze at -20 C or below. Â Avoid cycles of freezing and thawing. Â Expiration date is one (1) year from date of opening product.
- Hersteller:
- Aviva Systems Biology
- Typ:
- Antibodies: Monoclonal Antibody
- Datenblatt des Herstellers:html_datasheet.php